Metabolism and Clinical Significance of Triglycerides

  • Home
  • Metabolism and Clinical Significance of Triglycerides

Metabolism and Clinical Significance of Triglycerides

1Shihab Ahmed Shihab, 2Maryam Mosleh, 3Ali A. Al-fahham
1Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq
2Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq
3Faculty of Nursing, University of Kufa, Iraq


ABSTRACT:

Triglycerides, the principal form of fat storage in animals and humans, are essential in view of their roles in energy metabolism and regulation. Indeed, they have been ascribed very vital functional significance in a plethora of physiological processes, which extends to energy storage, metabolic signaling, and disease pathology. Biochemistry and metabolism of triglycerides is a multivaried area of science that includes different mechanisms that control synthesis, storage, and utilization in organisms. For many years, the issue of triglycerides and their relationship to cardiovascular disease (CVD) has been one of the central themes of research. Elevated triglyceride levels frequently associate with an elevated cardiovascular risk, but the situation is complex and multifaceted at all. It has now been reported that triglycerides could act not only as a biomarker regarding cardiovascular risk but also play an actual part in the fostering of cardiovascular disorders. The present literature review juxtaposes key findings on triglyceride metabolism, thereby underlining implications for health and disease, with the end to identify works currently associating triglyceride implications in cardiovascular health, and further to explore determinants of triglyceride levels gap that warrant further investigation.

   

REFERENCES :

1) Alves‐Bezerra, M.., & Cohen, D.. (2017). Triglyceride Metabolism in the Liver.. Comprehensive Physiology , 8 1 , 1-8 . http://doi.org/10.1002/cphy.c170012 
2) Arner, P.., Bernard, S.., Salehpour, M.., Possnert, G.., Liebl, Jakob., Steier, P.., Buchholz, B.., Eriksson, M.., Arner, E.., Hauner, H.., Skurk, T.., Rydén, M.., Frayn, K.., & Spalding, K.. (2011). Dynamics of human adipose lipid turnover in health and metabolic disease. Nature, 478, 110-113.
http://doi.org/10.1038/nature10426
3) Arrese, E.., & Soulages, J.. (2010). Insect fat body: energy, metabolism, and regulation.. Annual review of entomology , 55 , 207-25 . http://doi.org/10.1146/annurev-ento-112408-085356
4) Chapman, M.., Ginsberg, H.., Amarenco, P.., Andreotti, F.., Borén, J.., Catapano, A.., Descamps, O.., Fisher, E.., Kovanen, P.., Kuivenhoven, J.., Lesnik, P.., Masana, L.., Nordestgaard, B.., Ray, K.., Reiner, Ž.., Taskinen, M.., Tokgözoğlu, L.., Tybjærg‐Hansen, A.., & Watts, G.. (2011). Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. European Heart Journal , 32 , 1345 – 1361 . http://doi.org/10.1093/eurheartj/ehr112
5) Chau, M.., Gao, Jiaping., Yang, Qing., Wu, Zhidan., & Gromada, J.. (2010). Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway. Proceedings of the National Academy of Sciences , 107 , 12553 – 12558 . http://doi.org/10.1073/pnas.1006962107
6) Chiang, J.. (2013). Bile acid metabolism and signaling.. Comprehensive Physiology , 3 3 , 1191-21.
http://doi.org/10.1002/cphy.c120023
7) Dewey, Frederick E.., Gusarova, V.., Dunbar, Richard L.., O’Dushlaine, C.., Schurmann, C.., Gottesman, O.., McCarthy, S.., Hout, C.., Bruse, S.., Dansky, Hayes., Leader, J.., Murray, Michael F.., Ritchie, Marylyn D.., Kirchner, H. L.., Habegger, L.., López, A.., Penn, John., Zhao, A.., Shao, Weiping., Stahl, N.., Murphy, Andrew J.., Hamon, S.., Bouzelmat, Aurelie., Zhang, Rick., Shumel, B.., Pordy, R.., Gipe, D.., Herman, G.., Sheu, W. H.., Lee, I-T., Lee, I-T., Liang, Kae-Woei., Liang, Kae-Woei., Guo, Xiuqing., Rotter, Jerome I.., Chen, Y. I.., Kraus, William E.., Shah, Svati H.., Damrauer, S.., Small, Aeron M.., Rader, Daniel J.., Wulff, A.., Nordestgaard, B.., Tybjærg‐Hansen, A.., Hoek, A. V. D.., Princen, Hans M.G.., Ledbetter, David H.., Carey, David J.., Overton, J.., Reid, J.., Sasiela, W.., Banerjee, P.., Shuldiner, A.., Borecki, I.., Teslovich, Tanya M.., Yancopoulos, G.., Mellis, S.., Gromada, J.., & Baras, A.. (2017). Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. The New England Journal of Medicine , 377 , 211–221 . http://doi.org/10.1056/NEJMoa1612790
8) Do, Ron., Willer, C.., Schmidt, Ellen M.., Sengupta, Sebanti., Gao, Chi., Peloso, G.., Gustafsson, S.., Kanoni, S.., Ganna, A.., Chen, Jin., Buchkovich, Martin L.., Mora, S.., Beckmann, Jacques S.., Bragg-Gresham, J.., Chang, Hsing-Yi., Demirkan, A.., Hertog, H. M.., Donnelly, L.., Ehret, G.., Esko, T.., Feitosa, M.., Ferreira, T.., Fischer, K.., Fontanillas, P.., Fraser, Ross M.., Freitag, Daniel F.., Gurdasani, D.., Heikkilä, K.., Hyppönen, Elina., Isaacs, A.., Jackson, A.., Johansson, Å.., Johnson, T.., Kaakinen, M.., Kettunen, Johannes., Kettunen, Johannes., Kleber, M.., Li, Xiaohui., Luan, J.., Lyytikäinen, L.., Magnusson, P.., Mangino, M.., Mihailov, E.., Montasser, May E.., Müller-Nurasyid, Martina., Nolte, I.., O’Connell, J.., Palmer, C.., Perola, M.., Perola, M.., Perola, M.., Petersen, A.., Sanna, S.., Saxena, R.., Shah, Sonia., Shungin, D.., Sidore, C.., Song, C.., Strawbridge, R.., Surakka, I.., Surakka, I.., Tanaka, Toshiko., Teslovich, Tanya M.., Thorleifsson, G.., Herik, E. V. D.., Voight, B.., Volcik, K.., Waite, L.., Wong, Andrew., Wu, Ying., Zhang, Weihua., Absher, D.., Asiki, G.., Barroso, I.., Been, L.., Bolton, J.., Bonnycastle, L.., Brambilla, P.., Burnett, M.., Cesana, G.., Dimitriou, M.., Doney, A.., Döring, A.., Elliott, P.., Epstein, Stephen E.., Eyjolfsson, G.., Gigante, B.., Goodarzi, M.., Grallert, H.., Gravito, Martha L.., Groves, C.., Hallmans, G.., Hartikainen, Anna-Liisa., Hayward, C.., Hernandez, Dena G.., Hicks, Andrew A.., Hólm, H.., Hung, Y.., Illig, T.., Jones, Michelle R., Kaleebu, P.., Kastelein, J.., Khaw, K.., Kim, Eric., Klopp, N.., Komulainen, P.., Kumari, M.., Langenberg, C.., Lehtimäki, T.., Lin, Shih-Yi., Lindström, J.., Loos, Ruth J. F.., Mach, François., McArdle, W.., Meisinger, C.., Mitchell, Braxton D.., Müller, Gabrielle., Nagaraja, R.., Narisu, Narisu., Nieminen, T.., Nsubuga, R.., Olafsson, I.., Ong, Ken K., Palotie, A.., Papamarkou, T.., Pomilla, C.., Pouta, A.., Pouta, A.., Rader, Daniel J.., Reilly, M.., Ridker, P.., Rivadeneira, F.., Rudan, I.., Ruokonen, A.., Samani, N.., Scharnagl, H.., Seeley, Janet., Silander, K.., Silander, K.., Stančáková, A.., Stirrups, K.., Swift, A.., Tiret, L.., Uitterlinden, A.., Pelt, L. J. V.., Vedantam, S.., Wainwright, N.., Wijmenga, C.., Wild, Sarah H., Willemsen, G.., Wilsgaard, T.., Wilson, James F.., Young, E.., Zhao, Jinghua., Adair, Linda S.., Arveiler, D.., Assimes, T.., Bandinelli, S.., Bennett, F.., Bochud, M.., Boehm, B.., Boomsma, D.., Borecki, I.., Bornstein, S.., Bovet, P.., Burnier, M.., Campbell, Harry., Chakravarti, A.., Chambers, J.., Chen, Y. I.., Collins, F.., Cooper, Richard S.., Danesh, J.., Dedoussis, G.., Faire, U.., Feranil, A.., Ferrières, J.., Ferrucci, L.., Freimer, N.., Gieger, C.., Groop, L.., Gudnason, V.., Gyllensten, U.., Hamsten, Anders., Harris, T.., Hingorani, A.., Hirschhorn, J.., Hofman, A.., Hovingh, G. K.., Hsiung, C.., Humphries, Steve E.., Hunt, S.., Hveem, K.., Iribarren, C.., Järvelin, M.., Jula, A.., Kähönen, M.., Kaprio, J.., Kaprio, J.., Kesäniemi, Antero Y.., Kivimäki, M.., Kooner, J.., Koudstaal, P.., Krauss, R.., Kuh, D.., Kuusisto, J.., Kyvik, K.., Laakso, M.., Lakka, T.., Lind, L.., Lindgren, C.., Martin, Nicholas G.., März, Winfried., McCarthy, M. I.., McKenzie, C.., Meneton, P.., Metspalu, A.., Moilanen, L.., Morris, Andrew D.., Munroe, P.., Njølstad, I.., Pedersen, Nancy L., Power, C.., Pramstaller, P.., Price, Jackie F.., Psaty, B.., Quertermous, T.., Rauramaa, R.., Saleheen, D.., Salomaa, V.., Sanghera, D.., Saramies, J.., Schwarz, Peter E. H.., Sheu, Wayne Huey-Herng., Shuldiner, A.., Siegbahn, A.., Spector, T.., Stefansson, Kari., Strachan, David P.., Tayo, B.., Tremoli, E.., Tuomilehto, J.., Uusitupa, Matti., Duijn, C.., Vollenweider, P.., Wallentin, L.., Wareham, N.., Whitfield, J.., Wolffenbuttel, B.., Altshuler, D.., Ordovás, J.., Boerwinkle, E.., Palmer, Colin N. A.., Thorsteinsdóttir, U.., Chasman, D.., Rotter, Jerome I.., Franks, P.., Ripatti, S.., Cupples, L.., Sandhu, M.., Rich, S.., Boehnke, M.., Deloukas, P.., Mohlke, K.., Ingelsson, E.., Abecasis, G.., Daly, M.., Neale, B.., & Kathiresan, S.. (2013). Common variants associated with plasma triglycerides and risk for coronary artery disease. Nature genetics , 45 , 1345 – 1352 . http://doi.org/10.1038/ng.2795
9) Dongiovanni, P.., Petta, S.., Maglio, C.., Fracanzani, A.., Pipitone, R.., Mozzi, E.., Motta, B.., Kamińska, D.., Rametta, R.., Grimaudo, S.., Pelusi, S.., Montalcini, T.., Alisi, A.., Maggioni, M.., Kärjä, V.., Borén, J.., Käkelä, P.., Marco, V. Di., Xing, Chao., Nobili, V.., Dallapiccola, B.., Craxì, A.., Pihlajamäki, J.., Fargion, S.., Sjöström, L.., Carlsson, L.., Romeo, S.., & Valenti, Luca. (2015). Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology , 61 . http://doi.org/10.1002/hep.27490
10) Ekelund, U.., Luan, J.., Sherar, L.., Esliger, D.., Griew, P.., & Cooper, A.. (2012). Moderate to vigorous physical activity and sedentary time and cardiometabolic risk factors in children and adolescents.. JAMA , 307 7 , 704-12 . http://doi.org/10.1001/jama.2012.156
11) Ginsberg, H.., Packard, C.., Chapman, M.., Borén, J.., Aguilar-Salinas, C.., Averna, M.., Ference, B.., Gaudet, D.., Hegele, R.., Kersten, S.., Lewis, G.., Lichtenstein, A.., Moulin, P.., Nordestgaard, B.., Remaley, A.., Staels, B.., Stroes, E.., Taskinen, M.., Tokgözoğlu, L.., Tybjaerg-hansen, A.., Stock, Jane K.., & Catapano, A.. (2021). Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society. European Heart Journal, 42, 4791-4806 . http://doi.org/10.1093/eurheartj/ehab551
12) Guerrero‐Romero, F.., Simental‐Mendía, L.., González-Ortiz, M.., Martínez-Abundis, E.., Ramos-Zavala, M. G.., Hernández-González, S.., Jacques-Camarena, O.., & Rodríguez-Moran, M.. (2010). The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp.. The Journal of clinical endocrinology and metabolism , 95 7 , 3347-51 . http://doi.org/10.1210/jc.2010-0288
13) Han, T.., & Lean, M.. (2016). A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovascular Disease , 5 . http://doi.org/10.1177/2048004016633371
14) Healy, G.., Matthews, C.., Dunstan, D.., Winkler, E.., & Owen, N.. (2011). Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06.. European heart journal , 32 5 , 590-7 .
http://doi.org/10.1093/eurheartj/ehq451
15) Lin, Xiaochen., Zhang, Xi., Guo, Jianjun., Roberts, C.., McKenzie, S.., Wu, Wen‐Chih., Liu, Simin., & Song, Yiqing. (2015). Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease , 4 . http://doi.org/10.1161/JAHA.115.002014
16) Miller, Michael., Stone, N.., Ballantyne, C.., Bittner, V.., Criqui, M.., Ginsberg, H.., Goldberg, A.., Howard, W.., Jacobson, M.., Kris-Etherton, P.., Lennie, T.., Levi, M.., Mazzone, T.., & Pennathur, S.. (2011). Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.. Circulation , 123 20 , 2292-333 . http://doi.org/10.1161/CIR.0b013e3182160726
17) Musunuru, K.., Pirruccello, J.., Do, R.., Peloso, G.., Guiducci, C.., Sougnez, C.., Garimella, K.., Fisher, Sheila A., Abreu, J.., Barry, A.., Fennell, T.., Banks, E.., Ambrogio, L.., Cibulskis, K.., Kernytsky, A.., Gonzalez, Elena., Rudzicz, Nicholas., Engert, J.., DePristo, M.., Daly, M.., Cohen, Jonathan C.., Hobbs, H.., Altshuler, D.., Schonfeld, G.., Gabriel, S.., Yue, P.., & Kathiresan, S.. (2010). Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.. The New England journal of medicine, 363 23, 2220-7. http://doi.org/10.1056/NEJMoa1002926
18) Parhofer, K.. (2015). Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia. Diabetes & Metabolism Journal , 39 , 353 – 362 . http://doi.org/10.4093/dmj.2015.39.5.353
19) Rayner, K.., Esau, Christine., Hussain, F. N.., McDaniel, Allison L.., Marshall, Stephanie M.., Gils, J. V. van., Ray, T. D.., Sheedy, Frederick J.., Goedeke, L.., Liu, Xueqing., Khatsenko, O.., Kaimal, V.., Lees, C.., Fernández-Hernando, C.., Fisher, E.., Temel, R.., & Moore, K.. (2011). Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides. Nature , 478 , 404 – 407 . http://doi.org/10.1038/nature10486
20) Schönfeld, P.., & Wojtczak, L.. (2016). Short- and medium-chain fatty acids in energy metabolism: the cellular perspective. Journal of Lipid Research , 57 , 943 – 954 . http://doi.org/10.1194/jlr.R067629
21) Sinha, R.., Singh, B.., & Yen, P.. (2018). Direct effects of thyroid hormones on hepatic lipid metabolism. Nature Reviews Endocrinology, 14, 259-269. http://doi.org/10.1038/nrendo.2018.10
22) Tyagi, S.., Gupta, Paras., Saini, Arminder Singh., Kaushal, Chaitnya., & Sharma, Saurabh. (2011). The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. Journal of Advanced Pharmaceutical Technology & Research , 2 , 236 – 240 . http://doi.org/10.4103/2231-4040.90879
23) Wei, Min., Brandhorst, Sebastian., Shelehchi, Mahshid., Mirzaei, H.., Cheng, Chia-Wei., Budniak, J.., Groshen, S.., Mack, W.., Guen, Esra., Biase, S. Di., Cohen, Pinchas., Morgan, T.., Dorff, T.., Hong, K.., Michalsen, A.., Laviano, A.., & Longo, V.. (2017). Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Science Translational Medicine , 9 . http://doi.org/10.1126/scitranslmed.aai8700

  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *